Losartan, an angiotensin-II type 1 receptor blocker, attenuates CCl4-induced liver fibrosis with a positive impact on survival in mice

Journal Title: World Journal of Pharmaceutical Sciences - Year 2017, Vol 5, Issue 12

Abstract

Background: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin-II receptor blockers (ARBs) may provide synergistic effects to existing chemotherapies by reducing angiotensin II-mediated angiogenesis, fibrogenesis, mitogenesis and oxidative stress. Objective: We aimed to examine the effect of the ARB, losartan and the ACEIs, perindopril and fosinopril on carbon tetrachloride (CCl4)-induced liver fibrosis on the histopathologic level and assess their impact on survival of mice. Methods: liver fibrosis was induced by CCl4 and examined histologically. Mice were treated with silymarin (SI) (30 mg/kg), perindopril (PE) (1 mg/kg), fosinopril (FO) (2 mg/ kg) or losartan (LO) (10 mg/kg). Cumulative survival was done using the Kaplan-Meier method and the log-rank test. Results: The administration of PE and FO resulted in improved liver histology without survival benefits to mice. However, losartan demonstrated marked improvement of liver histology and a positive impact on survival which was comparable to silymarin. Conclusion: Interfering the renin-angiotensin system (RAS) through the blockade of angiotensin-II type 1 (AT1) receptors improved liver histology of CCl4-induced hepatic fibrosis that was associated with longer survival in mice. c

Authors and Affiliations

Rasha H. Abdelghany

Keywords

Related Articles

Evaluation of in-vitro Antioxidant and Anti-diabetic activities of leave aqueous extracts of Oudneya Africana

The aim of this study was to investigate the biological properties, including antioxidant, anti-diabetic activity and phytochemical analysis of Oudneya Africana R. Br.. Qualitative analysis of phytochemicals (flavonoid,...

A study of rheumatoid arthritis management with the triple combination of methotrexate + hydroxychloroquine + sulfasalazine and double combination of methotrexate + hydroxychloroquine

Rheumatoid arthritis is chronic multisystem disease, failure rate with monotherapy is high. The present study was designed to compare the efficacy and safety of triple combination of Methotrexate + Hydroxychloroquine + S...

Clinical evaluation of nirgundi oil used in ancient Indian medicine – in the management of non-healing ulcers

The management of infected/contaminated wounds modern science is using newer & newer antibiotics are becoming ineffective due to microbial resistance. Along with these antibiotics they use NSAID’S & Multivitamin containi...

Characterization of phytoconstituents and evaluation of gastrointestinal motility & anticonvulsant activities of Lagerstroemia Speciosalinn (bark)

Lagerstroemia Speciosalinn is an important medicinal plant for its traditional uses against different types of diseases. Therefore, the present study was conducted to detect possible chemicals (phytoconstituents), prove...

Purification and Structure Elucidation of Potential Cytotoxic Agents from Streptomyces parvus KJ623765

Fermentation of Streptomyces (S.) parvus (accession code KJ623765), a locally isolated Streptomyces strains from Egyptian soil sample, was carried out in a 14 L laboratory fermentor. The optimum fermentation conditions w...

Download PDF file
  • EP ID EP331182
  • DOI -
  • Views 77
  • Downloads 0

How To Cite

Rasha H. Abdelghany (2017). Losartan, an angiotensin-II type 1 receptor blocker, attenuates CCl4-induced liver fibrosis with a positive impact on survival in mice. World Journal of Pharmaceutical Sciences, 5(12), 121-126. https://europub.co.uk/articles/-A-331182